The Prostate

Cover image for The Prostate

1 May 2008

Volume 68, Issue 6

Pages 577–689

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. Potent Oncolytic activity of human enteroviruses against human prostate cancer (pages 577–587)

      Linda J. Berry, Gough G. Au, Richard D. Barry and Darren R. Shafren

      Version of Record online: 20 FEB 2008 | DOI: 10.1002/pros.20741

    2. Neuroendocrine transdifferentiation induced by VPA is mediated by PPARγ activation and confers resistance to antiblastic therapy in prostate carcinoma (pages 588–598)

      Adriano Angelucci, Paola Muzi, Loredana Cristiano, Danilo Millimaggi, AnnaMaria Cimini, Vincenza Dolo, Roberto Miano, Carlo Vicentini, Maria Paola Cerù and Mauro Bologna

      Version of Record online: 20 FEB 2008 | DOI: 10.1002/pros.20708

    3. Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo (pages 599–609)

      Zhaomei Mu, Paul Hachem, Harvey Hensley, Radka Stoyanova, Hae Won Kwon, Alexandra L. Hanlon, Sudhir Agrawal and Alan Pollack

      Version of Record online: 14 JAN 2008 | DOI: 10.1002/pros.20731

    4. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-Cell translocation gene 2 (pages 610–619)

      Ke-Hung Tsui, Wen-Chi Hsieh, Mei-Hsien Lin, Phei-Lang Chang and Horng-Heng Juang

      Version of Record online: 14 JAN 2008 | DOI: 10.1002/pros.20725

    5. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions (pages 620–628)

      Natalie J. Serkova, Eduard J. Gamito, Richard H. Jones, Colin O'Donnell, Jaimi L. Brown, Spencer Green, Holly Sullivan, Tammy Hedlund and E. David Crawford

      Version of Record online: 22 JAN 2008 | DOI: 10.1002/pros.20727

    6. The current state of preclinical prostate cancer animal models (pages 629–639)

      Kenneth J. Pienta, Cory Abate-Shen, David B. Agus, Ricardo M. Attar, Leland W.K. Chung, Norman M. Greenberg, William C. Hahn, John T. Isaacs, Nora M. Navone, Donna M. Peehl, Jonathon W. Simons, David B. Solit, Howard R. Soule, Terry A. VanDyke, Michael J. Weber, Lily Wu and Robert L. Vessella

      Version of Record online: 22 JAN 2008 | DOI: 10.1002/pros.20726

    7. A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions (pages 640–650)

      Kumiko Maruyama-Takahashi, Naoki Shimada, Teruyoshi Imada, Yoshimi Maekawa-Tokuda, Toshihiko Ishii, Jun Ouchi, Hideaki Kusaka, Hiromasa Miyaji, Shiro Akinaga, Akira Tanaka and Kenya Shitara

      Version of Record online: 22 JAN 2008 | DOI: 10.1002/pros.20728

    8. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines (pages 651–660)

      L. Chow, L. Rezmann, K. Imamura, L. Wang, K. Catt, C. Tikellis, W.J. Louis, A.G. Frauman and S.N.S. Louis

      Version of Record online: 20 FEB 2008 | DOI: 10.1002/pros.20738

    9. Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer (pages 661–674)

      Alan A. Aitchison, Abhi Veerakumarasivam, Maria Vias, Rajeev Kumar, Freddie C. Hamdy, David E. Neal and Ian G. Mills

      Version of Record online: 22 JAN 2008 | DOI: 10.1002/pros.20730

    10. Analysis of the gene coding for the BRCA2-Interacting protein PALB2 in hereditary prostate cancer (pages 675–678)

      Marc Tischkowitz, Nelly Sabbaghian, Anna M. Ray, Ethan M. Lange, William D. Foulkes and Kathleen A. Cooney

      Version of Record online: 20 FEB 2008 | DOI: 10.1002/pros.20729

    11. Potentiation of 2-Methoxyestradiol-Induced cytotoxicity by blocking endothelin A receptor in prostate cancer cells (pages 679–689)

      Nicola J. Mabjeesh, Alexander Shefler, Sharon Amir and Haim Matzkin

      Version of Record online: 20 FEB 2008 | DOI: 10.1002/pros.20734